Athersys plans to sell $12 million in securities to raise cash for operations
Athersys Inc., the Cleveland-based regenerative medicine company, could raise up to $12 million by selling its shares and warrants to “a single healthcare-focused U.S. institutional investor.”
Click here to read the complete story.
Story excerpt provided by Cleveland Business Journal.
Written by Mary Vanac.
Originally published August 15, 2022.
Leave a Reply